Non-Alcoholic Fatty Liver Disease (NAFLD) has currently emerged as common liver disorder compared to alcoholic liver disease. The prevalence of NAFLD in India varies from 9% in rural areas to 32% in urban populations. This incidence is reported to be the lowest in western India (44.1%) compared to the highest prevalence in northern states (72.4%). Available treatments are associated with certain side-effects. Recently a relation between gut and liver, i.e. gut-liver axis has been studied extensively. Modulation of gut may provide a natural mechanism to improve NAFLD associated complications. Moreover, patients with NAFLD have lower levels of omega-3 poly unsaturated fatty acids (PUFAs). Thus, supplementation of omega-3 PUFA is important for both, prevention and treatment of NAFLD. Vitamin E provides a significant antioxidant action in prevention of NAFLD progression. Therefore, modulating gut microbiota with probiotics may be an effective alternative along with established therapies like vitamin E and PUFA for better outcomes in the management of NAFLD.